|
X
1: 1 = Male, 2 = Female |
X
12: Haemoglobin(g/dL) |
|
X
2: Age, 57.6±10.3 |
X
13: Plt (×105/mL) |
|
X
3: Height (cm) |
X
14: AST (IU/L) |
|
X
4: Weight (kg) |
X
15: ALT (IU/L) |
|
X
5: Previous therapy with interferon 0 = no, 1 = yes |
X
16: Diabetes mellitus 0 = no, 1 = not determined, 2 = yes |
|
X
6: Previous therapy with interferon plus RBV 0 = no, 1 = yes |
X
17: Serum total cholesterol level (mg/dL) |
|
X
7: Initial dose of PEGIFN (µg) |
X
18: HCV RNA level before treatment (kIU/mL) |
|
X
8: Initial dose of RBV (mg) |
X
19: Total amount of PEGIFN administered (µg/kg/week) |
|
X
9: Serum creatinine level (g/dL) |
X
20: Total amount of RBV administered (mg/kg/day) |
|
X
10: WBC level (/mL) |
X
21: EVR 0 = no, 1 = yes |
|
X
11: RBC level (×106/mL) |
|
| Outcome |
| SVR 24 weeks after commencement of treatment 0 = no, 1 = yes |
